Követés
Balázs Győrffy
Balázs Győrffy
Full Professor, Semmelweis University, Hungarian Academy of Sciences, member of Academia Europaea
E-mail megerősítve itt: ttk.mta.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
B Györffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi
Breast cancer research and treatment 123 (3), 725-731, 2010
25952010
Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer
B Győrffy, P Surowiak, J Budczies, A Lánczky
PloS one 8 (12), e82241, 2013
15222013
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Á Nagy, A Lánczky, O Menyhárt, B Győrffy
Scientific reports 8 (1), 1-9, 2018
10682018
Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization
J Budczies, F Klauschen, BV Sinn, B Győrffy, WD Schmitt, ...
PloS one 7 (12), e51862, 2012
9492012
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
AM Szász, A Lánczky, Á Nagy, S Förster, K Hark, JE Green, ...
Oncotarget 7 (31), 49322, 2016
8022016
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
B Győrffy, A Lánczky, Z Szállási
Endocrine-related cancer 19 (2), 197-208, 2012
7492012
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
A Lánczky, Á Nagy, G Bottai, G Munkácsy, A Szabó, L Santarpia, B Győrffy
Breast cancer research and treatment 160 (3), 439-446, 2016
6532016
Pancancer survival analysis of cancer hallmark genes
Á Nagy, G Munkácsy, B Győrffy
Scientific reports 11 (1), 1-10, 2021
4092021
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
B Győrffy
Computational and structural biotechnology journal 19, 4101-4109, 2021
3422021
Jetset: selecting the optimal microarray probe set to represent a gene
Q Li, NJ Birkbak, B Gyorffy, Z Szallasi, AC Eklund
BMC bioinformatics 12 (1), 1-7, 2011
2932011
Multigene prognostic tests in breast cancer: past, present, future
B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai
Breast cancer research 17 (1), 11, 2015
2742015
Multigene prognostic tests in breast cancer: past, present, future
B Győrffy, C Hatzis, T Sanft, E Hofstatter, B Aktas, L Pusztai
Breast cancer research 17 (1), 11, 2015
2742015
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
O Menyhárt, Á Nagy, B Győrffy
Royal Society open science 5 (12), 181006, 2018
2622018
Pancancer survival analysis of cancer hallmark genes. bioRxiv
A Nagy, G Munkacsy, B Gyorffy
Probe ID: 206571_s_at p-value 3, 2020
2492020
Web-based survival analysis tool tailored for medical research (KMplot): development and implementation
A Lánczky, B Győrffy
Journal of Medical Internet Research 23 (7), e27633, 2021
2022021
Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations
B Györffy, P Surowiak, O Kiesslich, C Denkert, R Schäfer, M Dietel, ...
International journal of cancer 118 (7), 1699-1712, 2006
2022006
A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
Z Mihály, M Kormos, A Lánczky, M Dank, J Budczies, MA Szász, B Győrffy
Breast cancer research and treatment 140 (2), 219-232, 2013
1862013
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
DC Porter, E Farmaki, S Altilia, GP Schools, DK West, M Chen, BD Chang, ...
Proceedings of the National Academy of Sciences 109 (34), 13799-13804, 2012
1822012
Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla–surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast …
Á Sávolt, G Péley, C Polgár, N Udvarhelyi, G Rubovszky, E Kovács, ...
European Journal of Surgical Oncology (EJSO) 43 (4), 672-679, 2017
1732017
Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
L Magnani, A Stoeck, X Zhang, A Lánczky, AC Mirabella, TL Wang, ...
Proceedings of the National Academy of Sciences 110 (16), E1490-E1499, 2013
1682013
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20